Clinical Trials - PHAT

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06851559A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 WeeksNOT_YET_RECRUITINGPHASE22025-122027-032026-12
NCT06831344A Study to Evaluate Two Vonoprazan Orally Disintegrating Tablet Formulations Administered Without Water or Mixed With Water and Administered Via a Syringe Relative to the Vonoprazan Tablet in Healthy ParticipantsCOMPLETEDPHASE12025-02-142025-04-102025-04-05
NCT06391177A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice DailyCOMPLETEDPHASE12024-05-072024-09-192024-09-13
NCT06106022A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux DiseaseCOMPLETEDPHASE12023-11-012024-04-292024-04-16
NCT05366738A Study to Determine the Bioavailability of Vonoprazan Sprinkle Capsules on Pudding or on Applesauce Relative to a Vonoprazan Tablet in Healthy ParticipantsCOMPLETEDPHASE12022-05-182022-07-262022-07-01
NCT05343364A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux DiseaseCOMPLETEDPHASE12022-05-092023-06-132023-05-30
NCT05195528A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)COMPLETEDPHASE32022-01-172023-05-172022-11-21
NCT04799158A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux DiseaseCOMPLETEDPHASE22021-03-252022-01-172021-12-16
NCT04729101Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan and Lansoprazole in Healthy ParticipantsCOMPLETEDPHASE12021-01-282021-06-262021-06-12
NCT04558216Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy ParticipantsWITHDRAWNPHASE12020-09-302021-02-192021-02-07
NCT04545944Evaluation of Effect of Vonoprazan on Midazolam Pharmacokinetics in Healthy ParticipantsCOMPLETEDPHASE12020-09-152020-11-252020-11-13
NCT04167670Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori InfectionCOMPLETEDPHASE32019-12-102021-03-182021-03-10
NCT04124926Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive EsophagitisCOMPLETEDPHASE32019-10-282021-08-242021-07-29